Sharp Therapeutics Corp.
SHRX.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -51.99% | -36.73% | 56.18% | -42.13% | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -24.29% | -10.21% | -34.94% | 286.30% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -50.96% | -36.02% | 50.56% | -38.93% | -- |
|
|
|||||
| Total Current Assets | -50.96% | -36.02% | 50.56% | -38.93% | -- |
| Net Property, Plant & Equipment | -2.46% | -2.61% | -2.31% | -2.64% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | -- |
| Total Assets | -35.58% | -28.21% | 33.69% | -30.67% | -- |
|
|
|||||
| Total Accounts Payable | 40.57% | -39.59% | -5.56% | 35.15% | -- |
| Total Accrued Expenses | 386.76% | -3.49% | 15.67% | -59.61% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.37% | 124.95% | 14.52% | 16.02% | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -100.00% | 1,463.43% | -- |
| Total Other Current Liabilities | -- | -- | -100.00% | 1,463.43% | -- |
| Total Current Liabilities | 121.43% | -15.85% | -79.94% | 270.27% | -- |
|
|
|||||
| Total Current Liabilities | 121.43% | -15.85% | -79.94% | 270.27% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -0.77% | -5.47% | -1.12% | -1.08% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 31.87% | -8.49% | -53.82% | 93.97% | -- |
|
|
|||||
| Common Stock & APIC | 3.61% | 0.03% | 11.18% | 0.15% | -- |
| Retained Earnings | -10.25% | -4.68% | 2.42% | -16.37% | -- |
| Treasury Stock & Other | -211.80% | 30.38% | 230.65% | -426.23% | -- |
| Total Common Equity | -112.47% | -42.37% | 470.74% | -125.64% | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -112.47% | -42.37% | 470.74% | -125.64% | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -112.47% | -42.37% | 470.74% | -125.64% | -- |
|
|
|||||